Allen Goorin, MD
|Hospital Title||Associate in Medicine|
|Academic Title||Associate Professor of Pediatrics|
Dana-Farber Cancer Institute
44 Binney Street
Boston MA 02115
Dr. Goorin is a member of the Bone Tumor/Osteosarcoma Steering Committee through the Children's Oncology Group. His clinical research focuses on the treatment of pediatric osteosarcoma. He participates in and directs national and international clinical trials to develop new treatments for patients with newly diagnosed osteosarcoma or relapsed disease, using the treatment modalities of surgery, radiation therapy, and chemotherapy in attempts to cure these patients.
Trials with anti-angiogenic agents, and immunomodifier therapy are being developed to treat sarcoma patients.
About Allen Goorin
Dr. Goorin received his MD from University of Pittsburgh School of Medicine. He completed an internship at Saint Christopher's Hospital in Philadelphia, a residency at Boston Children's Hospital, and a fellowship at Boston Children's Hospital and Dana-Farber Cancer Institute.
- Palmert MR, Alexander SW, Goorin AM. Ovarian toxicity after chemotherapy: possible association with ifosfamide administration. Pediatr Blood Cancer. 2004 Mar;42(3):216-9. No abstract available.
- Goorin AM, Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal G, Gebhardt M, Schwartz CL, Link M, Grier HE. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. Journal of Clinical Oncology 2002; 20: 426-33.
- Ferguson WS, Harris MB, Goorin AM, Gebhardt MC, Link MP, Shochat SJ, Siegal GP, Devidas M, Grier HE. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. Journal of Pediatric Hematology Oncology 2001; 23: 340-8.
- Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP. Pediatric Oncology Group. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. Journal of Clinical Oncology 2003; 21: 1574-80.